Comments

Vera Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VERANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Vera Therapeutics (VERA) Forecast

News Earnings Vera Therapeutics (VERA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Vera Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VERA | Benzinga

Explore Vera Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VERA.

Open	$27.15
Close	-
Volume / Avg.	19.37K / 834.52K
Day Range	$26.42 - $27.17
52 Wk Range	25.99 - 51.61
Market Cap	$1.68B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	15.27%
Days to Cover	11.61

Recent News

This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Top 3 Health Care Stocks That Could Blast Off This Quarter

Avi Kapoor

What's Going On With Vera Therapeutics Stock?

Vera Therapeutics shares are trading lower by 4.7% Monday afternoon. The company announced an exclusive license agreement with Stanford University for VT-109.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.15
Close	-
Volume / Avg.	19.37K / 834.52K
Day Range	$26.42 - $27.17
52 Wk Range	25.99 - 51.61
Market Cap	$1.68B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	15.27%
Days to Cover	11.61

About Vera Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and com...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vera Therapeutics (VERA) stock?

You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.

View our list of the best stock brokerages

Who are Vera Therapeutics (VERA) competitors?

Other companies in Vera Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), Ascentage Pharma Group (NASDAQ:AAPG), Arcutis Biotherapeutics (NASDAQ:ARQT) and Mesoblast (NASDAQ:MESO).

What is the forecast, or price target, for Vera Therapeutics (VERA) stock?

Vera Therapeutics has a consensus price target of $50.58.

What is the current price for Vera Therapeutics (VERA)?

The stock price for Vera Therapeutics (NASDAQ: VERA) is $26.72 last updated March 26, 2025 at 10:06 AM EDT.

Does Vera Therapeutics (VERA) pay a dividend?

A quarterly cash dividend of 0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.

When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?

Vera Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Vera Therapeutics (VERA) going to split?

There is no upcoming split for Vera Therapeutics.

What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.